Contemporary HIV Treatment and Prevention 2022

Download All
Learn from the experts about identifying barriers to PrEP uptake, optimizing ART strategies for patients, incorporating the latest data on emerging and innovative ARV treatment or prevention strategies, and counseling patients on new and investigational ART regimens.
Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Roger Bedimo, MD, MS, FACP
Eric S. Daar, MD
Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN
Christopher B. Fox, MSN, RN, ANP-BC, AAHIVS
Jasjit Gill, BSPharm, PharmD
Gregory Huhn, MD, MPHTM
Princy N. Kumar, MD, FIDSA, MACP
Daniel R. Kuritzkes, MD
person default
Mary W. Montgomery, MD
person default
Melanie Nicol, PharmD, PhD
person default
Neha Pandit, PharmD, AAHIVP, BCPS
Paul E. Sax, MD
Babafemi Taiwo, MBBS
person default
Allison Webel, PhD, RN
Mitchell J. Wharton, PhD, RN, FNP-BC, CNS, ACRN
Timothy J. Wilkin, MD, MPH
David A. Wohl, MD
Darcy Wooten, MD

Video Modules

Hear from expert faculty as they present their insights on some of the most clinically relevant new data presented at AIDS 2022, including prevention strategies, oral therapies, long-acting therapies, and COVID-19 in PWH.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
person default Allison Webel, PhD, RN Mitchell J. Wharton, PhD, RN, FNP-BC, CNS, ACRN
Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: November 22, 2022 Expired: November 21, 2023

Hear from expert faculty members as they present nursing insights on some of the most clinically relevant new data presented at CROI 2022, including prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN Jasjit Gill, BSPharm, PharmD
Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 10, 2022 Expired: May 9, 2023

Listen to expert faculty as they discuss inequities in PrEP uptake in key populations, structural barriers to PrEP adoption, and solutions for expanding PrEP use.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Christopher B. Fox, MSN, RN, ANP-BC, AAHIVS
Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 14, 2022 Expired: June 13, 2023

Hear from expert faculty members as they present some of the most clinically relevant new data presented at CROI 2022 and discuss how they will incorporate the data on prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure strategies into their own practices.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Gregory Huhn, MD, MPHTM Daniel R. Kuritzkes, MD Babafemi Taiwo, MBBS
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: June 17, 2022 Expired: June 16, 2023

Hear from expert faculty members as they present some of the most clinically relevant new data presented at AIDS 2022 and discuss how they will incorporate the data on prevention strategies, oral therapies, long-acting therapies, cure strategies, COVID-19, and monkeypox into their own practices.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Princy N. Kumar, MD, FIDSA, MACP person default Mary W. Montgomery, MD David A. Wohl, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Registered Nurses: 1.5 Nursing contact hours Pharmacists: 1.5 contact hours (0.15 CEUs) Released: December 23, 2022 Expired: December 22, 2023

Podcasts

Listen to Timothy J. Wilkin, MD, MPH, discuss barriers to PrEP uptake in adolescents.

Timothy J. Wilkin, MD, MPH Released: November 7, 2022

Listen to Timothy J. Wilkin, MD, MPH, discuss barriers to PrEP uptake in the context of race.

Timothy J. Wilkin, MD, MPH Released: November 15, 2022

Listen to Timothy J. Wilkin, MD, MPH, discuss barriers to PrEP uptake for cisgender women.

Timothy J. Wilkin, MD, MPH Released: November 15, 2022

Listen to Timothy J. Wilkin, MD, MPH, discuss barriers to PrEP uptake for transgender women.

Timothy J. Wilkin, MD, MPH Released: November 15, 2022

Listen to Timothy J. Wilkin, MD, MPH, discuss barriers to PrEP uptake for people who inject drugs.

Timothy J. Wilkin, MD, MPH Released: November 15, 2022

Listen to Timothy J. Wilkin, MD, MPH, discuss solutions for expanding PrEP uptake.

Timothy J. Wilkin, MD, MPH Released: November 15, 2022

Listen to Paul E. Sax, MD, discuss what’s new in long-acting injectables for HIV treatment.

Paul E. Sax, MD Released: November 14, 2022

Listen to Paul E. Sax, MD, discuss the latest recommendations and options for HIV pre-exposure prophylaxis.

Paul E. Sax, MD Released: November 14, 2022

Listen to Roger Bedimo, MD, MS, FACP, discuss key considerations for switching ART in virologically suppressed patients who are pregnant or trying to conceive.

Roger Bedimo, MD, MS, FACP Released: October 3, 2022

Listen to Timothy J. Wilkin, MD, MPH, provide a case-based overview of switching antiretroviral therapy in a person with viral suppression on their current regimen who has a history of virologic failure with drug-resistance mutations.

Timothy J. Wilkin, MD, MPH Released: October 20, 2022

Learn about ART selection in treatment-naive PWH based on the latest guideline recommendations through case-based discussions by Princy N. Kumar, MD, FIDSA, MACP.

Princy N. Kumar, MD, FIDSA, MACP Released: December 29, 2022

Listen to this patient case from Princy N. Kumar MD, FIDSA, MACP, as she shares the latest data on weight gain after ART initiation.

Princy N. Kumar, MD, FIDSA, MACP Released: December 30, 2022

Downloadable Slidesets

Read expert faculty members’ summaries of key HIV studies from CROI 2022, including results from studies of prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Released: April 28, 2022

Read expert faculty members’ summaries of cutting-edge concepts in HIV care, including the latest for long-acting therapies and prevention.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Darcy Wooten, MD
Released: September 23, 2022

Read expert faculty members’ summaries of key HIV studies from CROI 2022, including results from studies of prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Daniel R. Kuritzkes, MD
Released: May 2, 2022

Read expert faculty summaries on the latest data in first-line ART therapy in diverse patients to assist with individualized ART selection.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Released: April 1, 2022

Read expert faculty members’ summaries of barriers and solutions to PrEP uptake in key populations including, adolescents, Black and Hispanic/Latinx people, cisgender women, transgender women, and people who inject drugs.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Gregory Huhn, MD, MPHTM
Released: May 4, 2022

Read expert faculty members’ summaries of state-of-the-art switch strategies in virologically suppressed patients, including switching ART in the setting of resistance, considerations for long acting injectables, and switching ART prior to or during pregnancy.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Paul E. Sax, MD
Released: May 6, 2022

Read expert faculty members’ summaries of barriers and solutions to PrEP uptake in key populations including, adolescents, Black and Hispanic/Latinx people, cisgender women, transgender women, and people who inject drugs.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Released: September 22, 2022

Read expert faculty members’ summaries of barriers and solutions to PrEP uptake in key populations including, adolescents, Black and Hispanic/Latinx people, cisgender women, transgender women, and people who inject drugs.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Released: September 23, 2022

Read expert faculty members’ summaries of cutting-edge concepts in HIV care, including the latest for long-acting therapies and prevention.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Released: May 31, 2022

Download slides to review expert insights into strategies for overcoming virologic failure in heavily treatment–experienced patients and selecting optimized switch regimens for virologically suppressed patients with underlying resistance and significant potential drug–drug interactions.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Eric S. Daar, MD
Released: December 13, 2022

Read expert faculty members’ summaries of key HIV studies from AIDS 2022, including results from studies of prevention strategies, oral therapies, long-acting therapies, cure, COVID-19 in PWH, and Monkeypox.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
David A. Wohl, MD
Released: September 23, 2022

Read expert faculty members’ summaries of key HIV studies from AIDS 2022, including results from studies of prevention strategies, oral therapies, long-acting therapies, and COVID-19 in PWH.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Released: September 23, 2022

Read expert nursing faculty members’ summaries of cutting-edge concepts in HIV care, including the latest for long-acting therapies and prevention.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Released: November 22, 2022

Download slides to review expert pharmacist insights into strategies for overcoming virologic failure in heavily treatment–experienced patients and selecting optimized switch regimens for virologically suppressed patients with underlying resistance and significant potential drug–drug interactions.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Released: January 10, 2023

Download slides to review expert nurse insights into strategies for overcoming virologic failure in heavily treatment–experienced patients and selecting optimized switch regimens for virologically suppressed patients with underlying resistance and significant potential drug–drug interactions.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Released: January 11, 2023

ClinicalThought

Major inequities in PrEP uptake, adherence, and persistence have been seen in Black and Hispanic/Latinx people, cisgender women, transgender women, adolescents, and people who inject drugs. Here’s how we can address them.

person default Neha Pandit, PharmD, AAHIVP, BCPS Released: December 2, 2022

We now have long-acting injectable options for both the treatment and prevention of HIV, with more to learn as we incorporate this exciting new paradigm. Here are my thoughts on key differences among available HIV prevention medications and the potential role of individual pharmacokinetic variability in the efficacy of long-acting options for prevention and treatment.

person default Melanie Nicol, PharmD, PhD Released: December 30, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings